IPO registrations (S-1, F-1) · Registrants

TESARO, Inc.

SEC CIK
1491576 · filings on EDGAR ↗
Registration
Form S-1, first filed 2012-03-23, last 2013-02-25; 2 initial registrations, 6 amendments
Outcome
Final prospectus filed 2012-06-28; declared effective 2012-06-27
Industry (SIC)
Pharmaceutical Preparations 2834
Incorporated in
DE
Business address
1000 WINTER STREET, SUITE 3300, Waltham, MA 02451
EIN
27-2249687
EDGAR entity type
operating
Insiders and CEO pay
TESARO, Inc. on the corporate pages

Offering terms

Proposed price range
$12.00–$15.00 per share (S-1/A filed 2012-06-19)
Final price
$13.50 per share, within the range (424B4 filed 2012-06-28, an initial public offering)
Shares sold
6,000,000
Gross proceeds
$81,000,000 before underwriting discounts and any over-allotment option
Listing
Nasdaq under the symbol TSRO
Lead underwriters
Citigroup
Syndicate
Morgan Stanley; Leerink Partners; BMO Capital Markets; Baird

Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.

Filings 15

FiledFormWhat it isName as filedEDGAR
2012-03-23S-1S-1 (registration)Tesaro, Inc.0001047469-12-003207 ↗
2012-05-17S-1/AS-1/A (amendment)TESARO, Inc.0001047469-12-006122 ↗
2012-05-25S-1/AS-1/A (amendment)TESARO, Inc.0001047469-12-006352 ↗
2012-06-19S-1/AS-1/A (amendment)TESARO, Inc.0001047469-12-006728 ↗
2012-06-22S-1/AS-1/A (amendment)TESARO, Inc.0001047469-12-006854 ↗
2012-06-27S-1/AS-1/A (amendment)TESARO, Inc.0001047469-12-006930 ↗
2012-06-27EFFECTEFFECT (declared effective)TESARO, Inc.9999999995-12-001969 ↗
2012-06-28424B4424B4 (final prospectus)TESARO, Inc.0001047469-12-006956 ↗
2012-06-29424B4424B4 (final prospectus)TESARO, Inc.0001047469-12-006982 ↗
2013-02-20S-1S-1 (registration)TESARO, Inc.0001047469-13-001278 ↗
2013-02-25S-1/AS-1/A (amendment)TESARO, Inc.0001047469-13-001540 ↗
2013-02-27S-1MEFS-1MEF (added securities)TESARO, Inc.0001104659-13-015403 ↗
2013-02-27EFFECTEFFECT (declared effective)TESARO, Inc.9999999995-13-000591 ↗
2013-02-28424B1424B1 (final prospectus)TESARO, Inc.0001047469-13-001953 ↗
2013-03-01424B4424B4 (final prospectus)TESARO, Inc.0001047469-13-001985 ↗

Prospectus pages read 4

FiledFormRead asRangePriceSharesProceedsListingUnderwritersWhat was foundDocument
2012-06-19S-1/Aregistration statement$12.00–$15.006,000,000-Nasdaq TSRO5primary document; range, shares headline, cover names 5document ↗
2012-06-22S-1/Aregistration statement--0primary document; no terms founddocument ↗
2012-06-27S-1/Aregistration statement--0primary document; no terms founddocument ↗
2012-06-28424B4final prospectus$13.506,000,000$81,000,000Nasdaq TSRO5primary document; price sentence, shares headline, proceeds table, cover names 5document ↗

Officers, directors and large holders Forms 3, 4 and 5

InsiderRoleTitleFilingsYearsOn this site
Alleva Lawrence MDirector152012–2019
BARRETT M JAMESTenPercentOwner82012–2018
BARRIS PETER JTenPercentOwner82012–2019
BASKETT FORESTTenPercentOwner82012–2019
CASH HARVEY BTenPercentOwner22012
CLEVELAND BRUCE AOther; TenPercentOwner32012–2013
Desai KevalOther; TenPercentOwner32012–2013
DRANT RYAN DTenPercentOwner42012–2015
Ehrlich Christopher BTenPercentOwner22012
GIANOS PHILIP TOther; TenPercentOwner32012–2013
Hedley Mary LynneDirector,OfficerPres & Chief Scientific Off.; Pres.&Chief Scientific Officer; Pres & CSO; President and COO; President & COO; PRESIDENT & COO; President & CSO112012–2019person page Fuzzy
Holmes W StephenOther; TenPercentOwner32012–2013
InterWest Management Partners X, LLCOther; TenPercentOwner32012–2013
INTERWEST PARTNERS X LPOther; TenPercentOwner32012–2013
KERINS PATRICK JTenPercentOwner72012–2019
Kjellson Nina SOther; TenPercentOwner32012–2013
Kliman Gilbert HOther; TenPercentOwner32012–2013
KOLLURI KRISHNA KITTUTenPercentOwner72012–2016person page Fuzzy
KRAMLICH C RICHARDTenPercentOwner22012
MOTT DAVID MDirector,TenPercentOwner122012–2019
MOULDER LEON O JRDirector,OfficerCEO; Chief Executive Officer; CHIEF EXECUTIVE OFFICER122012–2019
NASR KHALEDOther; TenPercentOwner32012–2013
NEA 13 GP, LtdTenPercentOwner72012–2019
NEA Partners 13, Limited PartnershipTenPercentOwner72012–2019
NEW ENTERPRISE ASSOCIATES 13 LPTenPercentOwner72012–2019
ORONSKY ARNOLD LDirector; Director,TenPercentOwner122012–2018
Pepper Douglas AOther; TenPercentOwner32012–2013
Rodgers Richard JOfficerEXECUTIVE VP AND CFO; Executive VP & CFO; Exec. Vice President & CFO32012–2013
Rosch Thomas LTenPercentOwner22012
SANDELL SCOTT DTenPercentOwner82012–2019
SEIDENBERG BETH CDirector162012–2019
Viswanathan RaviTenPercentOwner72012–2018
Walker Paul EdwardDirector42012–2014
Weller Harry RTenPercentOwner72012–2016
English Edward COfficerVice President & Controller; VP, Controller & Prin Acct Off; VP FINANCE, ADMIN. and PFO; V.P.Finance and Administration; VP Finance and Administration; V.P. of Finance & Admin.; VP of Finance & Administration; VP of Finance & Admin & P.F.O.; VP of Finance and Admin.172012–2017
Armitage James ODirector112013–2019
Fisher DouglasOther12013
PEARSON TIMOTHY ROfficerEVP, CFO; Executive VP and CFO; Executive VP & CFO; Exec. VP, CFO72014–2019
COLLIER EARL M JRDirector72014–2019
Farmer Joseph LOfficerSr VP, GC and Secretary; Sr VP, Gen Counsel & Secretary; Sr VP,Gen. Counsel & Secretary; Sr.VP, Gen.Counsel & Secretary; Sr.VP,Gen.Counsel & Secretary; SVP, GC and Secretary92015–2019person page Fuzzy
Nicholson Garry ADirector62015–2019
Hanke Jeffrey H.OfficerExecutive VP, R&D and CSO52015–2016
Bogle Grant C.OfficerSr. VP, Chief Commercial Ofc; Sr. VP, Chief Commercial Ofc.; Sr VP,Chief Commercial Officer; Sr.VP,Chief Commercial Officer; SVP & Chief Commercial Officer72015–2019
Huber Martin H. Jr.OfficerSr. VP, Chief Medical Officer; SVP & Cheif Medical Officer; SVP & Chief Medical Officer152015–2019
Khattar Jack A.Director,OfficerPresident, CEO12016
Patel KavitaDirector62016–2019
Oliveira OrlandoOfficerSVP & GM, International82017–2019
Witz PascaleDirector42018–2019
COVINO GREGORY FOfficerSVP, CAO, PAO; SVP,CAO,PAO32018–2019

Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.

Private offerings before or after (Form D)

First filedIssuerIndustryOfferingSoldInvestorsFilings
2016-04-18TESARO, Inc.Pharmaceuticals$49,999,960$49,999,96011
2016-03-10TESARO, Inc.Pharmaceuticals$154,999,915$154,999,91571

Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.

Also on this site Fuzzy

RecordName as filedWhereDatasetMatched by
Form D issuerTESARO, Inc.MAForm D private offeringsCIK (EXACT)
SEC filerTESARO, Inc.SEC filers (EDGAR)CIK (EXACT)
Business registrationTESARO, INC.State business registriesEIN (EXACT, as the state registration reports it)
Form 5500 plan sponsorTESARO, INC.EIN (EXACT)
Federal award recipientTESARO, INC.Federal spending (USAspending)name and state
Lobbying clientTESARO, INC.Federal lobbying (LDA)name and state
Lobbying clientTESARO, INC.Federal lobbying (LDA)name and state
Person pageJoseph L FarmerPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Officer)
Person pageKrishna Kittu KolluriPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner)
Person pageMary Lynne HedleyPeople (Form 990 officers, directors and employees)officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director,Officer)

Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.

Others with the same interests

SIC industry Pharmaceutical Preparations, MA first:

More with this interest.

In other datasets, the same topic (Health) in MA:

Interests: Pharmaceutical Preparations · Health